SOST and atherosclerosis: Therefore, body mass–related traits, including lean body mass, are not likely to be a pleiotropic pathway between sclerostin and atherosclerosis outcomes (Supplementary Table 9A, http://onlinelibrary.wiley.com/doi/10.1002/art.42538).